BioCentury | Nov 11, 2013
Company News

NeuroSystec, Otonomy deal

...tinnitus from an affiliate of NeuroSystec. Otonomy received preclinical, clinical and manufacturing data produced by NeuroSystec...
...delivery technology. The product is in preclinical testing. Otonomy said financial terms are not disclosed. NeuroSystec Corp....
BioCentury | Jun 28, 2004
Company News

Durect, NeuroSystec Corp. deal

...DRRX granted NeuroSystec exclusive worldwide rights to develop and market treatments for inner ear disorders using...
...and royalties. DRRX also received an equity stake in NeuroSystec. Durect Corp. (DRRX), Cupertino, Calif. NeuroSystec Corp....
Items per page:
1 - 2 of 2
BioCentury | Nov 11, 2013
Company News

NeuroSystec, Otonomy deal

...tinnitus from an affiliate of NeuroSystec. Otonomy received preclinical, clinical and manufacturing data produced by NeuroSystec...
...delivery technology. The product is in preclinical testing. Otonomy said financial terms are not disclosed. NeuroSystec Corp....
BioCentury | Jun 28, 2004
Company News

Durect, NeuroSystec Corp. deal

...DRRX granted NeuroSystec exclusive worldwide rights to develop and market treatments for inner ear disorders using...
...and royalties. DRRX also received an equity stake in NeuroSystec. Durect Corp. (DRRX), Cupertino, Calif. NeuroSystec Corp....
Items per page:
1 - 2 of 2